Annexon, Inc. Common Stock (ANNX) is a publicly traded Healthcare sector company. As of October 16, 2026, ANNX trades at $3.41 with a market cap of $682.48M and a P/E ratio of -3.18. ANNX moved -5.14% today. Year to date, ANNX is -34.67%; over the trailing twelve months it is +7.57%. Its 52-week range spans $1.29 to $7.18. Analyst consensus is buy with an average price target of $13.36. Rallies surfaces ANNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ANNX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.41 |
| Market Cap | $682.48M |
| P/E Ratio | -3.18 |
| EPS | $-1.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.18 |
| 52-Week Low | $1.29 |
| Volume | 4.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-206.69M |
| Gross Margin | 0.00% |
9 analysts cover ANNX: 0 strong buy, 6 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.36.